The RBB Fund, Inc. - US Treasury 3 Year Note ETF Price & Performance (UTRE)

HCA Healthcare has received a consensus recommendation of "Moderate Buy" from analysts, with a 12-month average price target of $385.67. While the stock has seen mixed ratings, it remains a strong performer, recently reporting quarterly earnings of $6.22 per share, surpassing expectations. A dividend increase to $0.72 per share has also been announced.1

Dun & Bradstreet's price target was cut by Needham & Company to $14.00 following weaker-than-expected quarterly earnings. The firm reported $0.27 EPS, falling short of analysts' $0.32 estimate. Despite challenges, the stock maintains a "Buy" rating from Needham, while other analysts hold a "Hold" consensus with a target price of $12.50.2

Cintas Corporation has been assigned a "Hold" consensus by analysts, with a 12-month price target averaging $198.46. The company recently posted quarterly earnings of $1.09 per share, exceeding expectations. A $0.39 dividend per share was declared, reflecting steady performance amid evolving market conditions.3